Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

34.83
Delayed Data
As of Mar 24
 +0.38 / +1.10%
Today’s Change
19.32
Today|||52-Week Range
42.49
+20.77%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close34.45
Today’s open34.58
Day’s range34.19 - 35.00
Volume1,209,729
Average volume (3 months)2,258,903
Market cap$4.2B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-14.37%
Earnings growth (next 5 years)+36.20%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book8.15

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+4.73+0.57%
OPKOPKO Health Inc+0.20+2.61%
MNKMallinckrodt Plc-0.09-0.21%
ALNYAlnylam Pharmaceutic...-0.70-1.33%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs